author-photo

Elisabeth Farrelly

9

Papers

211

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Reduction in incontinence product use and associated cost savings after onabotulinumtoxinA treatment in patients with overactive bladder

2021 Toxicon
Show All
- Source
- Cite
- Save
Citations (0)
MP17-04 REDUCTION IN INCONTINENCE PRODUCT USE AND ASSOCIATED COST SAVINGS AFTER ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER

2021 The Journal of Urology
Show All
- Source
- Cite
- Save
Citations (0)
OnabotulinumtoxinA is a well tolerated and effective treatment for refractory overactive bladder in real-world practice

2020 International Urogynecology Journal
Show All
- Source
- Cite
- Save
Citations (1)
Improvement in Urinary incontinence is Accompanied by a Reduction in Concomitant Medication Use Following OnabotulinumtoxinA Treatment for Idiopathic Overactive Bladder: Results From a Multinational Real-world Study

2019
Show All
- Source
- Cite
- Save
Citations (1)
Significant Reduction in Incontinence Episodes with OnabotulinumtoxinA and Clinically Meaningful Improvements in the Practical Aspects of Overactive Bladder Patients’ Daily Lives in Real-world Clinical Practice

2017 Neurourology and Urodynamics
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: A randomized, placebo-controlled, double-blind study

2007 Scandinavian Journal of Urology and Nephrology
Show All
- Source
- Cite
- Save
Citations (114)
Efficacy and safety of a novel system (NASHA/Dx copolymer using the implacer device) for treatment of stress urinary incontinence

2004 Urology
Show All
- Source
- Cite
- Save
Citations (38)
Treatment of stress urinary incontinence using a copolymer system: impact on quality of life.

2004 BJUI
Show All
- Source
- Cite
- Save
Citations (19)